Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns down below $2.98
Key levels
Resistance$3.50
Resistance$2.98
Latest news & SEC filings
No headlines in the last 90 days.
SciSparc is a clinical-stage pharmaceutical company developing drug candidates, including a proprietary oral PEA tablet formulation called CannAmide. Its pipeline is in late preclinical and early clinical stages, and it also holds rights to the MUSE endoscopic system and medical camera technology. The company operates mainly in Israel and Canada, targeting pharmacies, retail outlets, and future patients through third-party manufacturers and research partners.
Based on the company's 20-F filed Apr 29, 2026.
Nasdaq · Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SPRC.
Start Free Trial →Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
22
Moat Score
NONE
2/9
Piotroski Score
N/A
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 1 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Shrem Itschak | director | Sale | 462 | $5K | Jun 1, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
-54.6%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-91.13%
FCF Growth YoY
N/A%
Revenue Trend
STRONG
SEPT Investing tracks real-time dark pool institutional trades for SPRC, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:45:43 | $0.39 | 2,000 | $$773 | BUY |
| 16:43:47 | $0.36 | 2,500 | $$901 | SELL |
| 16:32:06 | $0.38 | 1,500 | $$565 | SELL |
| 15:27:57 | $0.38 | 1,000 | $$380 | SELL |
| 14:32:42 | $0.40 | 1,010 | $$407 | BUY |
5 dark pool trades shown · $$3K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for SciSparc Ltd. (SPRC) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →SciSparc Ltd. (SPRC) is at $0.36, down 9.59% (-$0.04) at the Nov 12, 2026 close.
SPRC last reported on Apr 23, 2026: EPS -$0.70.
SPRC trades at a P/E of 0.4 vs a Healthcare average of 18.5.
SPRC does not currently pay a dividend.
Resistance: $2.98, $3.50, $4.00.
Insider activity: NEUTRAL, 0 buys and 1 sells in the last 90 days.